MCHP
78
2
CMA
62
-18
ESS
44
-21
CMI
62
-9
REGN
44
-12
C
77
-4
DHI
45
-19
MOS
63
-3
XEL
39
-30
PNR
62
-16
F
54
-12
CFG
97
-2
CF
65
-4
MSI
57
-16
GS
65
-14
MAC
46
-24
EA
38
-25
XRAY
46
-9
CHRW
54
-20
FMC
43
-19
MCHP
78
2
CMA
62
-18
ESS
44
-21
CMI
62
-9
REGN
44
-12
C
77
-4
DHI
45
-19
MOS
63
-3
XEL
39
-30
PNR
62
-16
F
54
-12
CFG
97
-2
CF
65
-4
MSI
57
-16
GS
65
-14
MAC
46
-24
EA
38
-25
XRAY
46
-9
CHRW
54
-20
FMC
43
-19
Financhill
Back

iShares 20+ Year Treasury Bond ETF Vs. Kymera Therapeutics Industry Stock Comparison

Sell
36

TLT
iShares 20+ Year Treasury Bond ETF

Last Price:
$86.00
Seasonality Move:
1.87%
Buy
53

KYMR
Kymera Therapeutics

Last Price:
$43.43
Seasonality Move:
5.78%
Sell
36
iShares 20+ Year Treasury Bond ETF (TLT) is a Sell

Is iShares 20+ Year Treasury Bond ETF a Buy, Sell or Hold?

  • The current iShares 20+ Year Treasury Bond ETF [TLT] share price is $86.03. The Score for TLT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • TLT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $43.43. The Score for KYMR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TLT Stock Price Chart

What is iShares 20+ Year Treasury Bond ETF's stock price today?

  • The iShares 20+ Year Treasury Bond ETF share price today is $86.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TLT is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $43.43
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

TLT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.86 Buy
Relative Strength Index (14 RSI): 44.47 Sell
Chaikin Money Flow: 30360089 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.46 Buy
Relative Strength Index (14 RSI): 52.12 Buy
Chaikin Money Flow: -176647 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.14 - 47.42) Sell
Bollinger Bands (100): (27.24 - 41.98) Buy

TLT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.31 Sell
20-day SMA: 86.81 Sell
50-day SMA: 86.67 Sell
200-day SMA: 89.92 Sell
8-day EMA: 19.12 Buy
20-day EMA: 8.19 Buy
50-day EMA: 3.37 Buy
200-day EMA: 0.86 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.31 Sell
20-day SMA: 45.91 Sell
50-day SMA: 38.46 Buy
200-day SMA: 39.53 Buy
8-day EMA: 9.65 Buy
20-day EMA: 4.14 Buy
50-day EMA: 1.7 Buy
200-day EMA: 0.43 Buy

iShares 20+ Year Treasury Bond ETF Earnings Growth & TLT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.41 per share.

iShares 20+ Year Treasury Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):